The collaboration aims to support patient awareness, participation and representation in a clinical trial of Prothena’s Alzheimer’s drug candidate PRX012.
Kelly Collier has been promoted to senior vice president, assistant general counsel, while Peggie Fort has joined the company as vice president, inventory and demand management.